- Email: [email protected]
Reviewer Acknowledgement
VALUE IN HEALTH REGIONAL ISSUES 4C (2014) 117–118
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/locate/vhri
Reviewer Acknowledgement Value in Health Regional Issues would like to thank the following reviewers for reviewing manuscripts for this issue: Ara Amirjanyan, MS, MPH, Assistant Professor & Researcher, Yerevan State Medical University, Yerevan, Armenia Siniša Antolić, MPharm, MSc, MBA, Market Access, Pricing and Pharmacoeconomics Manager, Roche Ltd., Zagreb, Croatia Mamdouh Ayad, MD, Market Access Director, Johnson & Johnson (Middle East), Dubai, United Arab Emirates Mette Bøgelund, MSc, Director and Partner, Incentive, Holte, Denmark Imre Boncz, MD, MSc, PhD, Habil, Professor, Faculty of Health Sciences, University of Pécs, Pécs, Hungary Gina Buban, BBA, MS, Consultant, Freed Associates, Kensington, CA, USA Johanita Riette Burger, PhD, Medicine Outcomes Research Programme Coordinator, School of Pharmacy, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa Tarik Catic, MScPharm, Health Economics & Pharmacoeconomics Consultant, Sarajevo, Bosnia and Herzegovina Stephanie Chen, PhD, Associate Director, Health Economics and Outcome Research, Actavis, NJ, USA Dalia Dawoud, PhD, MSc, BSc, Research Officer, Health Economics, Centre for Health Economics & Medicines Evaluation, Institute of Medical and Social Care Research, Bangor University, Bangor, UK Hakan Ergun, MD, Professor in Pharmacology, Faculty of Medicine, Clinical Pharmacology, Ankara, Turkey Charles C. Ezenduka, MSc, MBA, Lecturer/PEOR Consultant, Department of Clinical Pharmacy & Pharmacy Management, Faculty of Pharmaceutical Sciences Nnamdi Azikiwe University Awka, Awka, Nigeria Viliam Foltán, Professor RNDr, CSc, Head, Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia Edith Frénoy, MA, MSc, Director, Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Wolfgang Habacher, PhD, Head of Core Unit-Health Sciences, Health-Institute for Biomedicine and Health Sciences, Joanneum Research, Graz, Austria Ryan N. Hansen, PharmD, PhD, RPh, FACA, Patient-Centered Outcomes, Research Scholar, Acting Assistant Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA Lanis L. Hicks, PhD, Professor and Associate Chair, Health Management & Informatics, University of Missouri, MO, USA Anke-Peggy Holtorf, MBA, PhD, Managing Director, Health Outcomes Strategies, Basel, Switzerland Mohamed Izham b. Mohamed Ibrahim, PhD, Professor of Social & Administrative Pharmacy College of Pharmacy, Qatar University, Doha, Qatar Mihajlo Jakovljevic, MD, PhD, Head, Graduate Health Economics & Pharmacoeconomics Curricula, Associate Professor, Clinical Pharmacology Specialist, The Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia Ales Kminek, MD, MBA, Market Access Manager, AstraZeneca Central Europe, Prague, Czech Republic Guvenc Kockaya, MD, MSc, Vice President, Turkish Health Economics and Policy Association, Ankara, Turkey Alexander Kostyuk, MD, PhD, Chair of Health Policy & Health Technology Assessment Department, Kazakh Medical University for Continuing Education, CEO at Kazakh Agency for Health Technology Assessment, Astana City, Kazakhstan Irina Kozhanova, DPhil, Lecturer, Belarusian State Medical University, Minsk, Belarus Michael Lees, Oncology Lead, WWHEOR, Europe, Paris, France Jane Maina, PhD, Independent Public Health and Development Consultant, Plano, TX, USA Manoela Manova, MPharm, PhD, Associate Professor, Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University, Sofia, Bulgaria Nikolay Matveev, PhD, MD, MPH, Senior Health Economics Manager, Moscow, Russia Shelley McGee, BPharm, BCom, M Health Econ, Health Economist, MRC/Wits Rural Public Health and Health Transitions Unit, Wits University School of Public Health, Johannesburg, South Africa Andriy Moshyk, MSc, Manager, Health Economics, Bristol-Myers Squibb Canada, Montreal, QC, Canada Claudia Nicolay, PhD, Senior Research Scientist, European Statistics, Eli Lilly, Bad Homburg, Germany Eric Nsiah-Boateng, MSc, MPH, BSc, Planning and Programming Officer, National Health Insurance Authority (NHIA), Accra, Ghana 2212-1099$36.00 – see front matter Copyright & 2014, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. http://dx.doi.org/10.1016/j.vhri.2014.09.003
118
VALUE IN HEALTH REGIONAL ISSUES 4C (2014) 117–118
Agnes Nyabigambo, MSc, BSc, Research Fellow, Infectious Diseases Institute, College of Health Sciences, Kampala, Uganda Robert Plisko, MSc, Head of Economic Department, President, HTA Consulting, Cracow, Poland Anne Postulka, MD, Director of Medical and Economic Value Europe, Cepheid Europe, Maurens Scopont, France Sondos Samara, MSc, Clinical Pharmacy, Quality Manger, Environmental Laboratory for Microbiological and Chemical Analysis, Amman, Jordan Yevgeniy Samyshkin, MSc, Director, Health Economics and Outcomes Research & Real-World Evidence Solutions, IMS Health, London, UK Enrique Seoane-Vazquez, PhD, Director, International Center for Pharmaceutical Economics and Policy, Associate Professor, Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA Asrul Akmal Shafie, BPharm, Pg Dip Health Econ, PhD, Associate Professor, Program Chairman, Discipline of Social & Administrative Pharmacy, Universiti Sains Malaysia, Penang, Malaysia Segev Shani, PhD, MBA, MHA, Vice President Medical & Regulatory Affairs, Neopharm Group, Petach-Tikva, Israel Ismail A. Suleiman, BPharm, MPharm, PhD, FPCPharm, Senior Lecturer, Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria Monika Szkultecka-Debek, MD, PhD, Market Access Leader CEE Region, Roche Polska Sp. z o.o., Warsaw, Poland Daniel Tucker, MBBS, FRACGP, FRSPH, Primary Care Physician, Director in Health Economics Consulting, Costing Health Pty. Ltd., Hobart, Tasmania, Australia Adina Turcu-Stiolica, PhD, Lecturer & Chair of Pharmaceutical Marketing, University of Medicine and Pharmacy of Craiova, Faculty of Pharmacy, Craiova, Romania Milan Vocelka, MSc, Health Economist, State Institute for Drug Control, Prague, Czech Republic Surrey Walton, PhD, Associate Professor, Department of Pharmacy Systems Outcomes and Policy, University of Illinois, Chicago, IL, USA Albert Wertheimer, BS, MBA, PhD, Professor of Pharmacy Economics, Temple University, Philadelphia, PA, USA Hongbo Yang, PhD, Manager, Analysis Group, Inc., Boston, MA, USA Anna Zawada, MSc, Director of Transparency Council Department, Agency for Health Technology Assessment in Poland AHTAPol, Warsaw, Poland
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/locate/vhri
Reviewer Acknowledgement Value in Health Regional Issues would like to thank the following reviewers for reviewing manuscripts for this issue: Ara Amirjanyan, MS, MPH, Assistant Professor & Researcher, Yerevan State Medical University, Yerevan, Armenia Siniša Antolić, MPharm, MSc, MBA, Market Access, Pricing and Pharmacoeconomics Manager, Roche Ltd., Zagreb, Croatia Mamdouh Ayad, MD, Market Access Director, Johnson & Johnson (Middle East), Dubai, United Arab Emirates Mette Bøgelund, MSc, Director and Partner, Incentive, Holte, Denmark Imre Boncz, MD, MSc, PhD, Habil, Professor, Faculty of Health Sciences, University of Pécs, Pécs, Hungary Gina Buban, BBA, MS, Consultant, Freed Associates, Kensington, CA, USA Johanita Riette Burger, PhD, Medicine Outcomes Research Programme Coordinator, School of Pharmacy, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa Tarik Catic, MScPharm, Health Economics & Pharmacoeconomics Consultant, Sarajevo, Bosnia and Herzegovina Stephanie Chen, PhD, Associate Director, Health Economics and Outcome Research, Actavis, NJ, USA Dalia Dawoud, PhD, MSc, BSc, Research Officer, Health Economics, Centre for Health Economics & Medicines Evaluation, Institute of Medical and Social Care Research, Bangor University, Bangor, UK Hakan Ergun, MD, Professor in Pharmacology, Faculty of Medicine, Clinical Pharmacology, Ankara, Turkey Charles C. Ezenduka, MSc, MBA, Lecturer/PEOR Consultant, Department of Clinical Pharmacy & Pharmacy Management, Faculty of Pharmaceutical Sciences Nnamdi Azikiwe University Awka, Awka, Nigeria Viliam Foltán, Professor RNDr, CSc, Head, Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia Edith Frénoy, MA, MSc, Director, Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Wolfgang Habacher, PhD, Head of Core Unit-Health Sciences, Health-Institute for Biomedicine and Health Sciences, Joanneum Research, Graz, Austria Ryan N. Hansen, PharmD, PhD, RPh, FACA, Patient-Centered Outcomes, Research Scholar, Acting Assistant Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA Lanis L. Hicks, PhD, Professor and Associate Chair, Health Management & Informatics, University of Missouri, MO, USA Anke-Peggy Holtorf, MBA, PhD, Managing Director, Health Outcomes Strategies, Basel, Switzerland Mohamed Izham b. Mohamed Ibrahim, PhD, Professor of Social & Administrative Pharmacy College of Pharmacy, Qatar University, Doha, Qatar Mihajlo Jakovljevic, MD, PhD, Head, Graduate Health Economics & Pharmacoeconomics Curricula, Associate Professor, Clinical Pharmacology Specialist, The Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia Ales Kminek, MD, MBA, Market Access Manager, AstraZeneca Central Europe, Prague, Czech Republic Guvenc Kockaya, MD, MSc, Vice President, Turkish Health Economics and Policy Association, Ankara, Turkey Alexander Kostyuk, MD, PhD, Chair of Health Policy & Health Technology Assessment Department, Kazakh Medical University for Continuing Education, CEO at Kazakh Agency for Health Technology Assessment, Astana City, Kazakhstan Irina Kozhanova, DPhil, Lecturer, Belarusian State Medical University, Minsk, Belarus Michael Lees, Oncology Lead, WWHEOR, Europe, Paris, France Jane Maina, PhD, Independent Public Health and Development Consultant, Plano, TX, USA Manoela Manova, MPharm, PhD, Associate Professor, Department of Social Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Medical University, Sofia, Bulgaria Nikolay Matveev, PhD, MD, MPH, Senior Health Economics Manager, Moscow, Russia Shelley McGee, BPharm, BCom, M Health Econ, Health Economist, MRC/Wits Rural Public Health and Health Transitions Unit, Wits University School of Public Health, Johannesburg, South Africa Andriy Moshyk, MSc, Manager, Health Economics, Bristol-Myers Squibb Canada, Montreal, QC, Canada Claudia Nicolay, PhD, Senior Research Scientist, European Statistics, Eli Lilly, Bad Homburg, Germany Eric Nsiah-Boateng, MSc, MPH, BSc, Planning and Programming Officer, National Health Insurance Authority (NHIA), Accra, Ghana 2212-1099$36.00 – see front matter Copyright & 2014, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. http://dx.doi.org/10.1016/j.vhri.2014.09.003
118
VALUE IN HEALTH REGIONAL ISSUES 4C (2014) 117–118
Agnes Nyabigambo, MSc, BSc, Research Fellow, Infectious Diseases Institute, College of Health Sciences, Kampala, Uganda Robert Plisko, MSc, Head of Economic Department, President, HTA Consulting, Cracow, Poland Anne Postulka, MD, Director of Medical and Economic Value Europe, Cepheid Europe, Maurens Scopont, France Sondos Samara, MSc, Clinical Pharmacy, Quality Manger, Environmental Laboratory for Microbiological and Chemical Analysis, Amman, Jordan Yevgeniy Samyshkin, MSc, Director, Health Economics and Outcomes Research & Real-World Evidence Solutions, IMS Health, London, UK Enrique Seoane-Vazquez, PhD, Director, International Center for Pharmaceutical Economics and Policy, Associate Professor, Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA Asrul Akmal Shafie, BPharm, Pg Dip Health Econ, PhD, Associate Professor, Program Chairman, Discipline of Social & Administrative Pharmacy, Universiti Sains Malaysia, Penang, Malaysia Segev Shani, PhD, MBA, MHA, Vice President Medical & Regulatory Affairs, Neopharm Group, Petach-Tikva, Israel Ismail A. Suleiman, BPharm, MPharm, PhD, FPCPharm, Senior Lecturer, Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria Monika Szkultecka-Debek, MD, PhD, Market Access Leader CEE Region, Roche Polska Sp. z o.o., Warsaw, Poland Daniel Tucker, MBBS, FRACGP, FRSPH, Primary Care Physician, Director in Health Economics Consulting, Costing Health Pty. Ltd., Hobart, Tasmania, Australia Adina Turcu-Stiolica, PhD, Lecturer & Chair of Pharmaceutical Marketing, University of Medicine and Pharmacy of Craiova, Faculty of Pharmacy, Craiova, Romania Milan Vocelka, MSc, Health Economist, State Institute for Drug Control, Prague, Czech Republic Surrey Walton, PhD, Associate Professor, Department of Pharmacy Systems Outcomes and Policy, University of Illinois, Chicago, IL, USA Albert Wertheimer, BS, MBA, PhD, Professor of Pharmacy Economics, Temple University, Philadelphia, PA, USA Hongbo Yang, PhD, Manager, Analysis Group, Inc., Boston, MA, USA Anna Zawada, MSc, Director of Transparency Council Department, Agency for Health Technology Assessment in Poland AHTAPol, Warsaw, Poland